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Research impact: Detailed characterization of the infective subglottic secretions that cause 
ventilator-associated pneumonia (VAP) in mechanically ventilated patients has not been 
performed before, and should suggest targeted interventions for the prevention of VAP. This 
study shows that intubation and mechanical ventilation in critically ill patients creates an 
inflammatory subglottic environment in which mucin hyper-secretion and enhanced viscosity 
is associated with neutrophil infiltration, impaired neutrophil function, release of neutrophil 
elastase, and enrichment of VAP-causing pathogens. Enhanced subglottic mucus removal 
and/or disruption appears to be a logical target for improved VAP prevention, and should be 
the focus of future trials.    
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At a Glance Summary:  
 
Scientific Knowledge on the Subject  
“Blind” subglottic secretion drainage (SSD) significantly reduces VAP in mechanically 
ventilated patients. However remarkably little is known about the subglottic 
microenvironment in critically ill patients, and an improved understanding seems likely to 
suggest ways of improving the efficacy of SSD.   
 
What the Study Adds to the Field  
The study shows for the first time that, in critically ill patients, prolonged mechanical 
ventilation is associated with mucin hyper-secretion, mucus hyper-viscosity, neutrophilic 
inflammation, reduced microbiological diversity and enrichment of known respiratory 
pathogenic bacteria in subglottic secretions. Neutrophil proteases are secreted into the 
subglottic environment. We demonstrate that mucin from the subglottis of mechanically 
ventilated patients impairs the capacity of neutrophils to migrate, and to phagocytose and kill 
bacteria, and that the dysfunction is reversed upon treatment with a mucolytic agent. The 
study also adds a novel air-liquid interface model using primary human subglottic epithelium, 
in which subglottic mucin promotes growth and invasion of bacterial pathogens. These data 
begin to explain the association between subglottic host defense dysregulation, 
microbiological changes and VAP, and importantly suggest novel preventive strategies.   
 
Online data supplement: This article has an online data supplement, which is accessible 
from this issue's table of content online at www.atsjournals.org 
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ABSTRACT  
 
Rationale: Aspiration of infective subglottic secretions causes ventilator-associated 
pneumonia (VAP) in mechanically ventilated patients. Mechanisms underlying subglottic 
colonization in critical illness have not been defined, limiting strategies for targeted 
prevention of VAP. 
 
Objectives: To characterize subglottic host defense dysfunction in mechanically ventilated 
patients in the intensive care unit (ICU). To determine whether subglottic mucin contributes 
to neutrophil phagocytic impairment and bacterial growth.   
 
Methods: Prospective subglottic sampling in mechanically ventilated patients (intubated for 
four or more days), and newly intubated control patients (intubated for less than 30 minutes). 
Isolation and culture of primary subglottic epithelial cells from controls.  Laboratory analysis 
of host innate immune defenses. 
 
Measurements and Main Results: Twenty-four patients in the ICU and 27 newly intubated 
control patients were studied. Subglottic ICU samples had significantly reduced 
microbiological diversity and contained potential respiratory pathogens. The subglottic 
microenvironment in ICU was characterized by neutrophilic inflammation, significantly 
increased pro-inflammatory cytokines and neutrophil proteases, and altered physical 
properties of subglottic secretions, including accumulation of mucins. Subglottic mucin from 
ICU patients impaired the capacity of neutrophils to phagocytose and kill bacteria. 
Phagocytic function was reversible upon treatment with a mucolytic agent. Subglottic mucus 
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promoted growth and invasion of bacterial pathogens in a novel air-liquid interface model of 
primary human subglottic epithelium. 
 
Conclusions: Mechanical ventilation in ICU is characterized by substantial mucin secretion 
and neutrophilic inflammation. Mucin impairs neutrophil function and promotes bacterial 
growth. Mucolytic agents reverse mucin-mediated neutrophil dysfunction. Enhanced mucus 
disruption and removal has potential to augment preventive benefits of subglottic drainage. 
 
Word count: 249 words 
 
Key words: Critical care, mucoproteins, neutrophils, phagocytosis, ventilator-associated 
pneumonia. 
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TEXT  
 
INTRODUCTION  
Ventilator-associated pneumonia (VAP) is a common complication in the intensive care unit 
(ICU), with 9 - 27% of intubated and mechanically ventilated patients developing the 
condition (1-3). VAP remains the most commonly fatal infection in critical illness, with an 
overall attributable mortality of 13% (4). VAP significantly increases the length and cost of 
ICU stay (5),
 
accounts for half of all antibiotics given in critical care (6), and is commonly 
associated with antibiotic-resistant pathogens
 
(7-9).  
 
Introduction of the endotracheal tube (ETT) is a key contributing factor in VAP, providing a 
conduit for invasion of the airways with virulent microorganisms (10, 11). Bacteria cultured 
from the upper airway, above the ETT cuff prior to development of VAP, correlate strongly 
with organisms subsequently isolated from the lungs (12-14). Micro-aspiration of infected 
secretions from the subglottis (the region located immediately below the vocal cords, and 
directly above the ETT cuff) into the lung is considered a key component in the pathogenesis 
of VAP. Indeed, subglottic secretion drainage (SSD) has consistently emerged as an effective 
strategy for prevention of VAP (15-20), resulting in SDD being recommended in key 
guidelines and position statements (21-25). Despite this, little is known about the subglottic 
microenvironment in critically ill patients. Identification of factors associated with bacterial 
colonization of the subglottis would likely suggest novel, logical targets for improved 
prevention of VAP.  
 
The aims of this study were therefore to characterize subglottic host defenses in critically ill 
patients intubated in ICU, through a systematic evaluation of subglottic microbes, 
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neutrophils, mucus and epithelium. Our data propose a significant role for mucins in 
neutrophil dysfunction and propagation of bacterial growth. Some of the results of these 
studies have been previously reported in the form of an abstract (26). 
 
 
 
METHODS  
 
Patients and volunteers 
Patients who were intubated and mechanically ventilated for ≥4 days were recruited from two 
ICUs. Controls had elective laryngoscopy under general anesthesia for a range of upper 
airway symptoms of unidentified cause. Both groups had subglottic secretions aspirated 
under direct endoscopic vision. Controls also had subglottic brushings collected for epithelial 
culture using a sheathed cytology brush (BC-202D-5010, Olympus, Tokyo, Japan). Healthy 
volunteers provided blood to generate neutrophils for in vitro experiments. Further details 
relating to subglottic sampling and blood sampling are i  the online supplement. Informed, 
witnessed assent (from a relative or main carer for patients in the ICU) or informed, written 
consent (from controls and healthy volunteers) was obtained. The relevant research ethics 
committees approved the study. 
 
Processing of subglottic aspirates and blood 
Leukocytes were isolated from freshly aspirated mucus samples treated with 0.08% 
dithiothreitol (DTT, a mucolytic agent) (27) and from whole blood (28). Isolated cells were 
counted using a hemacytometer. Cytospins were prepared and cells stained with Giemsa to 
allow identification at light microscopy. Details of processing are in the online supplement.  
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Bacterial and fungal identification in subglottic aspirates  
Semi-quantitative bacterial and fungal culture, in addition to 16S rRNA bacterial profiling 
was performed on subglottic aspirates (details are contained in the online supplement) (29). 
 
Quantification of inflammatory cytokines, complement factors, mucins, DNA and 
proteases  
Cytokines were assayed by V-PLEX and U-PLEX kits (Meso Scale Diagnostics, MD, USA). 
Human neutrophil elastase (HNE) was quantified by enzyme-linked immunosorbent assay 
(ELISA, Abcam, MA, USA). Cytometric bead array (Becton Dickinson Biosciences, NJ, 
USA) was used to quantify C5a des-Arg (a stable form of activated complement factor 5). A 
Quanti-iT flourometric assay kit (Thermofisher, MA, USA) was used to quantify double-
stranded DNA (dsDNA). Further details are provided in the online supplement. 
 
Neutrophil viability  
Proportions of viable, apoptotic or necrotic cells were estimated using flow cytometry. 
Neutrophils were stained with Annexin V (Ann V, which binds to phosphatidylserine on the 
outer surface of apoptotic cells) and propidium iodide (PI, a vital dye that only enters and 
stains cells with a compromised cell wall, such as necrotic or late apoptotic cells). Samples 
were analyzed immediately using a FACSCanto II flow cytometer (Becton Dickinson 
Biosciences, NJ, USA) and the percentage of cells defined as AnnV-/PI-, AnnV+/PI- or PI+, 
corresponding to live, early apoptotic or late apoptotic/necrotic cells respectively (see online 
supplement for greater detail and representative flow cytometry plots) (30).  
 
Phagocytosis and bacterial killing by neutrophils 
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Phagocytosis by mucus- or blood-derived neutrophils was estimated using flow cytometric 
quantification of pHrodo® Green Staphylococcus aureus Bioparticles® (Thermofisher, MA, 
USA) taken up by neutrophils (see online supplement for greater detail and representative 
flow cytometry plots) (31). Neutrophils were also incubated with live Pseudomonas 
aeruginosa and bacterial killing estimated as a percentage of P. aeruginosa colony forming 
units (CFU), determined by serial dilution and incubation on Lennox B agar plates, compared 
to a no neutrophil control (see online supplement) (32).  
 
Neutrophil chemotaxis assay 
Chemotaxis was determined as the proportion of neutrophils migrating into the lower 
chamber of a transwell permeability support (3.0 µm pore size, Corning, NY, USA) 
containing recombinant human interleukin (IL)-8 (Sigma-Aldrich, Dorset, UK; see online 
supplement) (33).  
 
Mucus analysis and mucin purification 
Shear viscosity of mucus was analyzed at 37ºC using a Kinexus Pro (Malvern Instruments, 
Worcester, UK) with 60mm parallel plates, according to the manufacturer’s instructions. A 
table of shear rates was produced over the range of 0-100s
-1
. Analysis was performed on 
rSpace software (version 1.6, Malvern Instruments, Worcester, UK) (34). The percentage dry 
weight of mucus was calculated using a microbalance to compare weight before and after 
drying the sample at 80ºC overnight. The principal mucins in mucus are MUC5B and 
MUC5AC and these were quantified by ELISA (Abcam, MA, USA).   
 
Mucin was purified from subglottic aspirates as a single species by cesium chloride 
equilibrium density gradient ultracentrifugation and dialysis (see online supplement) (35). 
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The mucin applied to cells in experiments therefore contained “total mucin”, containing 
representative proportions of all constituent mucins. Total mucin (across a range of 
concentrations) was incubated with neutrophils (and the phagocytosis/bacterial killing assays 
repeated) and with epithelial cells (as described below).  
 
Primary subglottic epithelial cell (PSEC) culture  
Subglottic brushings were collected from newly intubated theater attender controls as 
described above. Epithelial cells were isolated and grown at air-liquid interface (ALI) (see 
online supplement) (36). Cultures were assessed (a) by light microscopy for the presence of 
apical cilia and (b) using an epithelial volt-ohmmeter (World Precision Instruments, FL, 
USA) to assess trans-epithelial electrical resistance. Separately, cells were stained with anti-
cytokeratin antibody conjugated with Alexa Fluor® 647 (Biolegend, CA, USA), counter-
stained with DAPI nuclear stain, and assessed by confocal microscopy (details are described 
in the online supplement). 
 
Bacterial-epithelial co-culture experiments 
PSECs, cultured at ALI, had their apical mucus layer replaced with purified mucin and were 
co-cultured with P. aeruginosa. At 7 hours the mucin layer was removed and the epithelial 
layer homogenized. Bacterial growth was determined by serial dilution and incubation on LB 
agar plates (see online supplement) (37).  
 
Statistical Analysis 
Analysis was conducted with Prism (Graphpad Software, CA, USA). Nonparametric data 
were analyzed by the Mann-Whitney U test for two variables and by the Kruskal-Wallis test 
for greater than two variables, using Dunn’s post-hoc analysis test. Categorical data were 
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assessed by Fisher’s exact test. Correlations were assessed by linear regression. P < 0.05 was 
considered statistically significant.  
 
 
 
 
RESULTS 
 
Patients and controls 
We enrolled 24 patients intubated and mechanically ventilated for ≥4 days and 31 newly (and 
transiently) intubated non-ICU controls. Of these, all the ICU patients and 27 controls had 
recoverable subglottic secretions and were included in the study. Clinical and demographic 
information for both cohorts are described in Table 1. Extended clinical details for the ICU 
cohort are described in the online supplement (Table E1). No oral antiseptics or ETTs coated 
with antimicrobial agents were used in our patients. Two of the 24 ICU patients had a clinical 
diagnosis of VAP made at the time of study or in the following 4 days.  
 
Microbiological analysis 
The range of organisms identified in the subglottic aspirates of intubated and ventilated ICU 
patients was significantly lower than that of newly intubated controls (Figure 1). More 
species recognized as potential respiratory pathogens complicating critical illness (e.g. 
Pseudomonas, Enterococcus) were isolated from patients in the ICU (Figure 1 and online 
supplement Figure E1). Control samples tended to contain more commensal species, each in 
larger numbers, than ICU patients’ samples (Figure 1, Figure E1, Table E2). 
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Analysis of mucins 
To establish the constituents and physical properties of subglottic mucus aspirates we 
assessed viscosity and percentage dry weight (percentage of solids), and quantified double 
stranded DNA (dsDNA) and the concentrations of the principal airway mucins MUC5B and 
MUC5AC (Figure 2). Mucus derived from patients in the ICU was significantly more 
viscous, and had a greater dry weight. In addition, significantly higher concentrations of 
dsDNA and mucin MUC5B (but not MUC5AC) were demonstrated, as compared to mucus 
from newly intubated controls. MUC5B was by far the most abundant mucin in mucus from 
ICU patients.  
 
To investigate potential correlates between mucin concentrations in the subglottic aspirates 
and clinical status, total mucin concentrations in ICU subglottic aspirates were compared 
with various parameters. Subglottic mucin concentrations showed a weak, positive (but 
statistically significant) correlation with duration of intubation/mechanical ventilation and 
increasing age (r=0.48, p<0.05 for both; see online supplement Figure E2). 
 
Analysis of markers of inflammation 
Significantly higher concentrations of inflammatory cytokines, activated complement, and 
extracellular HNE were observed in subglottic aspirates from the ICU patients (Table 2).  
 
Neutrophil concentrations were also significantly elevated in the subglottic aspirates taken 
from patients in the ICU compared to controls (Figure 3). There was no significant difference 
in macrophage concentration (Figure 3). No significant difference was demonstrable between 
the portion of viable or apoptotic neutrophils in the two cohorts (Figure 3). A representative 
flow cytometry plot is shown in the online supplement, along with evidence that mucin itself 
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did not compromise neutrophil viability (Figure E3). Given the large number of mucus-
derived neutrophils we went on to investigate the phagocytic capacity of these cells upon 
extraction from mucus samples. There was no demonstrable deficiency in phagocytic 
capacity of neutrophils extracted from the subglottic mucus of long-term intubated ICU 
patients, compared to newly intubated controls (Figure 3).  
 
Mucin-neutrophil interactions 
To assess whether the high mucin environment in the subglottis was responsible for 
neutrophil dysfunction, we incubated blood-derived neutrophils from healthy volunteers (who 
were not intubated at any point) with purified mucin, derived from subglottic secretions taken 
from patients in ICU. Mucin (at a concentration of 20 mg/mL) induced a significant reduction 
in neutrophil chemotaxis compared to a mucin-free control (Figure 4A). This mucin 
concentration was selected as it approximated to the median concentration of mucin in ICU 
patients, and was more than twice the highest mucin concentration observed in any control. 
Neutrophil migration appeared to be paralyzed by high concentrations of mucin (see online 
supplement video, Figure E4). Additionally, mucin (20 mg/mL) significantly impaired the 
capacity of neutrophils to kill P. aeruginosa, one of the two most commonly isolated 
pathogens in VAP (Figure 4B) (1, 9). There was no significant reduction in either neutrophil 
chemotaxis or bacterial killing at the range of mucin concentrations found in subglottic 
aspirates from newly intubated controls. To corroborate these findings a further assay of 
phagocytosis by neutrophils from healthy volunteers was performed using S. aureus 
bioparticles (S. aureus is the other of the two commonest pathogens causing VAP (1, 9)). 
Mucin at 20 mg/mL again impaired phagocytosis (Figure 4C). DTT (a mucolytic agent) 
reversed the mucin-associated impairment of phagocytosis (Figure 4C).  
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Effects of mucus on bacterial interaction with subglottic epithelium 
To investigate potential interactions between infected mucus and the subglottic epithelium, 
we developed a novel in vitro ALI model of human PSECs and extensively characterized the 
model to determine how closely it recapitulated the in vivo environment (further detail and 
illustration is provided in the online supplement, Figures E5-7). An epithelial phenotype was 
confirmed by expression of pan-cytokeratin and at ALI the cells demonstrated a highly 
differentiated pseudostratified respiratory epithelium with apical cilia (Figure E5). Trans-
epithelial electrical resistance was demonstrated at ALI and maintained in prolonged culture 
(Figures E5 and E6). Cultures also secreted appropriate airway mucins into an apical mucus 
layer (Figure E7).  
 
The human PSEC model was used to investigate the interaction of the epithelium, P. 
aeruginosa, and purified mucin derived from patients in the ICU. Replacement of the PSECs’ 
apical mucus layer with purified ICU-derived mucin (at a concentration of 20 mg/mL), 
induced a significant increase in bacterial colony forming units (CFU), compared to a mucin-
free control (Figure 5). This was evident in both the apical mucin layer, and in the epithelial 
homogenate. 
 
 
 
DISCUSSION 
 
Our data suggest, for the first time, that intubation and mechanical ventilation in the ICU over 
4 or more days is associated with neutrophilic inflammation and reduced microbiological 
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diversity within the subglottic environment. Neutrophil function appears to be significantly 
impaired, at least in part due to an excess of subglottic mucin, which promotes colonization 
and growth of potential respiratory pathogens, and potentially invasion of the subglottic 
epithelium. These findings may explain the validated importance of SSD in the prevention of 
VAP, and suggest further preventive strategies. We also describe a novel in vitro model that 
reproduces several key features of the human subglottis.    
Aspiration of infective subglottic secretions into the lung causes VAP in mechanically 
ventilated patients. We found that the microbiology of subglottic aspirates from intubated, 
critically ill patients shows reduced diversity and the presence of more pathogenic organisms 
associated with VAP, compared with controls.  
 
It has previously been reported that even short-term tracheal intubation, for several hours, can 
cause significant mucosal inflammation around the tracheal cuff (38), and impede the 
function of the mucociliary escalator (39). This inflammation was characterized by a rapid 
accumulation of granulocytes and increased pro-inflammatory and chemotactic agents, such 
as IL-8, IL-6, IL-1β and C5a (38). We also found elevated pro-inflammatory cytokines in 
subglottic aspirates from patients in the ICU, which may have contributed to the recruitment, 
and persistence, of unexpectedly high concentrations of viable neutrophils. The release of 
HNE, a serine protease with a broad range of substrates, is likely to have further precipitated 
the local inflammation, which may in turn contribute to a cycle of further neutrophil 
migration (40).  
 
The persisting inflammation described above may have contributed to the differences in the 
mucus constituents and physical properties of ICU-derived mucus. In particular IL-8, IL-6 
and IL-1β have been shown to up-regulate MUC5B (41-44), and in murine models of cystic 
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fibrosis-like lung disease neutrophil elastase appears to drive mucus hyper-secretion (45). In 
human studies, the inflammatory stimulus of e-cigarettes simultaneously produces airway 
neutrophilia and mucus hyper-secretion (46).  
 
Mucins are one of the main constituents of the mucus that covers epithelial surfaces, and are 
vital in determining mucus function as a lubricant and selective barrier. The predominant 
secreted airway mucins are MUC5B and MUC5AC (47). The proportion of these two airway 
mucins within the airway is not well characterized in man. Both are secreted by goblet cells 
and seromucinous glands of the lamina propria at the apical epithelium (47). Consistent with 
our data, MUC5B appears to be the airway mucin most responsive to stimulation by 
inflammatory mediators. In keeping with this, MUC5B is the predominant airway mucin in 
chronic obstructive pulmonary disease (48).   
 
Acute mucin hyper-secretion is thought to aid innate immune defense by trapping particles 
(47). Nevertheless prolonged, extensive or inappropriate mucin hyper-secretion has been 
implicated in airway obstruction and poor clearance of pathogens in numerous respiratory 
diseases (47). Our observation of high concentrations of mucin and dsDNA, as well as 
elevated mucus viscosity, suggest a potential failure of the mucus layer as an effective 
lubricant in the subglottis of critically ill patients. In parallel with the failure of the 
mucociliary escalator, demonstrated previously after intubation (39), this is likely to promote 
mucus stasis and a failure to clear pathogens. 
 
The neutrophil is the key innate immune cell involved in clearance of bacteria and fungi (49). 
Mucin’s inhibitory effect on phagocytosis by neutrophils is the most profound for any studied 
by our group to date. We have previously studied the effects of several cytokines and 
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mediators (most of those described in Table 2) on neutrophil phagocytosis and found that 
only supra-physiological concentrations of C5a drive down-regulation (32). In contrast, GM-
CSF and IFN-gamma improve neutrophil phagocytosis. We cannot exclude the possibility 
that C5a contributed to impaired neutrophil phagocytosis in our patients but the 
concentrations described here are associated with a small impairment of neutrophil 
phagocytosis in in vitro experiments (in contrast to the profound effect of mucin). Based on 
the available evidence we believe the most likely sequence is that, in the context of critical 
illness: intubation markedly upregulates local inflammation and cytokine production; this 
simultaneously recruits an excess of neutrophils and drives mucus hyper-secretion; mucus 
(with a smaller potential contribution from C5a) profoundly impairs the ability of neutrophils 
to clear bacteria, while mucus itself provides a compatible environment for bacterial growth; 
dysfunctional neutrophils release HNE, which may contribute further to local inflammation, 
potentially creating a vicious cycle.  
 
We observed no demonstrable difference in phagocytic function between subglottic mucus-
derived neutrophils from patients in ICU or controls (Figure 3C). It should be emphasized 
that neutrophil functions were not measured in mucus aspirated fresh from patients (as 
neutrophils are “trapped” in the mucus, and the number of neutrophils and other leukocytes 
cannot be standardized), and that Figure 3C shows neutrophils liberated from mucus by a 
mucolytic (and studied at a known concentration).  
 
Blood neutrophil phagocytic capacity was also similar in ICU patients and controls. This was 
unsurprising, as in our experience very profound critical illness is required to impair blood 
neutrophil capacity (50) (our use of healthy volunteers’ blood neutrophils in Figure 3C could 
be criticized but we were confident that control patients’ blood neutrophil phagocytosis 
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would be normal, and restricted their extra involvement to subglottic aspiration under direct 
vision).  
 
We found that the phagocytic capacity of neutrophils in the subglottic aspirates from ICU 
patients and from controls was lower than that in blood neutrophils. This is consistent with 
our previous findings that extravascular neutrophils have lower phagocytic capacity than 
blood neutrophils from the same patient (32 and Hellyer TP, unpublished data). However, the 
phagocytic capacity of subglottic neutrophils from ICU patients remained equivalent to that 
from controls, and remained adequate for phagocytosis. While intubation and the 
inflammatory milieu may make a contribution to impaired neutrophil function, we believe 
these data suggest that neutrophils are functionally “trapped” by mucus. Importantly, 
however, they appear to retain function when removed from the mucus. We therefore went on 
to study the effect of purified mucin (from ICU patients) on healthy neutrophils. An in vitro 
cystic fibrosis model has suggested that high mucin concentrations may adversely affect 
neutrophils’ capacity for chemotaxis and bacterial killing (33).  
 
Purified mucin (predominantly containing MUC5B and MUC5AC) at a concentration and 
ratio typically found in intubated, critically ill patients impaired the capacity of healthy 
neutrophils to migrate towards a chemoattractant and to phagocytose and kill bacteria. 
Importantly, a mucolytic agent capable of breaking down mucin’s polymeric structure, 
restored normal phagocytic function (Figure 4C) to levels observed in subglottic neutrophils 
from control patients (Figure 3C). This supports the earlier data suggesting that neutrophil 
function can be restored upon liberation from mucus. 
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The novel human PSEC ALI model provides the potential to study subglottic diseases and 
potentially test therapeutic agents with a sub-site-specific in vitro model. The model provided 
evidence that subglottic mucin promotes growth and invasion of bacterial pathogens. This 
was a preliminary exploration of this concept and further validation is needed with other 
laboratory and clinical strains of VAP-producing pathogens, and the addition of neutrophils 
to the co-culture in the future.  
 
We believe that the identification of excess subglottic mucus as (i) a substrate for bacterial 
propagation and (ii) a “disabling trap” for neutrophils, from which they can be functionally 
rescued, has some simple but potentially important clinical implications. In particular, more 
effective subglottic clearance by aspiration under direct vision and/or by physical or chemical 
disruption of subglottic mucus seems likely to decrease local infection and inflammation, 
while simultaneously creating an environment for more effective neutrophil function. Several 
of the ICU patients in this study were already having SSD, yet subglottic mucus was freely 
aspirated from all patients under direct vision, suggesting SSD is sub-optimally effective. We 
therefore believe the simple interventions of aspiration under direct vision and/or mucus 
disruption should be assessed in clinical trials with a view to establishing whether they can 
prevent VAP more effectively than SSD alone. Such studies will require careful design and 
substantial patient numbers in order to test whether VAP is effectively prevented.  
 
In conclusion, intubated critically ill patients have an inflammatory subglottic phenotype 
characterized by mucin MUC5B hyper-secretion, emergence of potential respiratory 
pathogens, and release of neutrophil proteases such as HNE. The data suggest that more 
effective early removal and/or disruption of subglottic mucus represents an attractive strategy 
for improving prevention of VAP. 
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Figure 1 
ICU subglottic aspirates are characterized by reduced microbiological diversity and the 
presence of more species recognized as potential respiratory pathogens than control 
secretions. (A) Semi-quantitative bacterial and fungal culture of subglottic aspirates. (B) 16S 
rRNA bacterial profiling of subglottic aspirates. Observed operational taxonomic 
units (OTUs) and Shannon alpha diversity are demonstrated. The boxplots show the upper 
and lower quartiles and median, whiskers represent the range. (C) Hierarchical clustering of 
subglottic aspirate samples by bacterial relative abundance at OTU level. The row above the 
heat map shows ICU samples (orange) and control samples (blue) where each column 
represents a patient’s sample. The 30 most abundant bacterial OTUs are displayed on the heat 
map. A; Mann–Whitney U test, B; Kruskal-Wallis test, **p<0.01, ***p<0.001 (A; ICU n = 
23, control n = 25. B/C; ICU n = 24, control n = 20). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 30 of 70
For Review Only
 
Figure 2 
ICU aspirates are more dehydrated and viscous, and contained a greater concentration of 
dsDNA and MUC5B, but not MUC5AC, than control mucus. (A) Mucus shear viscosity was 
analyzed at 37°C. Values are expressed as pascal-seconds (Pa·s) at a shear rate of 1 s
-1
. (B) 
Aspirates were weighed before and after dehydration overnight at 80°C. The percentage solid 
was then calculated. (C) dsDNA concentration was quantified by Quant-iT assay kit. (D) 
Mucin MUC5B and MUC5AC concentrations were quantified by ELISA. Each dot 
represents a sample from an individual patient. Long horizontal bars indicate medians, shorter 
horizontal bars indicate interquartile range. Statistical analysis was by Mann–Whitney U test, 
*p < 0.05, **p<0.01, ****p<0.0001.  
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Figure 3 
ICU subglottic aspirates are dominated by high numbers of viable neutrophils, capable of 
phagocytosis. (A) Cells were extracted from subglottic aspirates by treatment with 0.08% 
DTT. Differential cell count was then performed using a hemacytometer and cytospin 
preparations. (B) Extracted cells were incubated with Annexin V and propidium iodide. 
Viable, early apoptotic and late apoptotic/necrotic cells were determined by flow cytometric 
gating of neutrophils. No significant difference between the two cohorts was demonstrated. 
(C) Cells were extracted from the whole blood of ICU patients or healthy volunteers (HV) 
using dextran sedimentation, or the mucus of ICU patients/control patients after treatment 
with 0.08% DTT. Extracted cells were incubated at 37°C for 1 hour with serum-opsonized 
pHrodo® green S. aureus Bioparticles. Phagocytosis was determined by flow cytometry. A 
negative control sample on ice was used in all experiments. Data in A and B are presented as 
box and whisker plots where the horizontal line depicts the median, boxes the interquartile 
range and whiskers the range. In C, each dot represents a sample from an individual. Long 
horizontal bars indicate medians, shorter horizontal bars indicate interquartile range. 
Statistical analysis was by Kruskal-Wallis test and Dunn’s post hoc test, *p<0.05, 
****p<0.0001 (A; ICU n = 18, control n = 7. B; ICU n = 18, control n = 8).  
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Figure 4 
Purified ICU-derived mucin inhibits neutrophil function and this effect is reversible with 
mucolytic treatment. (A) Neutrophil chemotaxis was measured using carboxyfluorescein 
succinimidyl ester (CFSE)-labeled neutrophils incubated within a transwell insert (3.0 µm 
pore size). The number of neutrophils that migrated from the apical compartment to the lower 
compartment (containing IL-8 at 10 ng/mL) at 3 hours was established. (B) Bacterial killing 
was determined using P. aeruginosa PA01 (opsonized using serum from the same donor who 
provided neutrophils) incubated with neutrophils for 30 minutes. Serial dilution on agar 
plates was performed, and colonies counted at 24 hours to derive a percentage reduction in 
colony forming units (CFU), measured against a sample without neutrophils. (C) Neutrophil 
phagocytosis pre- and post-mucolytic treatment was measured. Cells were incubated in mucin 
for 30 minutes prior to treatment with 0.08% dithiothreitol (DTT) for 5 minutes, centrifuged 
and re-suspended in a solution without mucin. Untreated cells and DTT-treated cells were 
then incubated at 37°C for 1 hour with pHrodo® green S. aureus Bioparticles® (opsonized 
using serum from the same donor who provided neutrophils). Phagocytosis was determined 
by flow cytometric gating of viable neutrophils with ingested particles versus a control 
sample on ice. Data are expressed as median and 95% confidence interval. Kruskal-Wallis 
test and Dunn’s post hoc test were used to compare the differences against the control 
without mucin. *p<0.05. (A; n = 6, B; n = 5; C n = 6). 
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Figure 5 
Purified subglottic mucin from ICU patients increases bacterial growth and invasion in 
bacterial-epithelial co-culture experiments. The mucus layer of PSECs cultured at ALI was 
removed and replaced with 50 µL of purified ICU-derived mucin (0, 5, 10 and 20 mg/mL), 
and incubated for 1 hour (37°C 5% CO2). P. aeruginosa [5µl (2x10
7
 CFU/mL), strain PA01] 
was then applied apically and incubated for 7 hours. Bacterial growth in the mucin layer (A) 
and epithelial homogenate (B) was determined by serial dilution on agar plates, counting 
colony-forming units (CFU) at 24 hours. Data are expressed as median and 95% CI. Kruskal-
Wallis test and Dunn’s post hoc test were used to compare samples and the control without 
mucin, *p<0.05, n = 4. 
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TABLES 
 
 
Table 1. Demographic and clinical data for patient and control groups. 
 
Abbreviations: ICU = intensive care unit; IQR = interquartile range; NA = not applicable;  
 
* 
By Mann–Whitney U test
 
† 
By Chi Squared test  
‡ 
At time of subglottic aspiration or during ICU admission prior to sampling 
 
 
 
 
 
ICU patients 
(n=24) 
Newly intubated 
controls (n=27) 
P Value 
Median age, years (range) 66 (20 – 79) 58 (35 – 79) 0.43
*
 
Percentage of patients male 63 59 >0.99
†
 
Median (IQR) time mechanically 
ventilated 
5 (4 – 6) days 9 (5 – 10) minutes  
ICU mortality, % 42 NA  
Percentage receiving immunosuppressive 
drugs (including corticosteroids)
‡
 
21 0  
Percentage receiving systemic 
antimicrobial drugs
‡
 
92 0  
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Table 2. Concentrations of cytokines and other mediators in subglottic aspirates. 
Definition of abbreviations: C5a des-Arg, stable breakdown product of activated complement 
factor 5; GM-CSF, granulocyte-macrophage colony-stimulating factor; HNE, human 
neutrophil elastase; ICU = intensive care unit; IFN, interferon; IQR, interquartile range; Th, T 
helper cell. The Mann–Whitney U test was used for statistical comparisons.  
 
ICU patients  Newly intubated controls  P Value 
Median IQR n Median IQR n  
Pro-inflammatory cytokines  
IL-8, pg/mL 43685 8285 - 106242 20 2412  819 - 4411 26 <0.0001 
IL-6, pg/mL 1469  514 – 3801 21 12 4 - 27 21 <0.0001 
IL-1β, pg/mL 3686 372 -12696 23 88 42 – 145 22 <0.0001 
IL-2, pg/mL 4.4  2.0 – 112.5 19 1.1  0.5 – 3.8 13 0.0265 
Th2 cytokines   
IL-13, pg/mL 226 136 – 869 21 40 12 – 185 14 0.0062 
Pro-inflammatory, non-
cytokine mediators 
 
C5a des-Arg, ng/mL 46.8  10.9 – 68.8 22 1.8  0.4 – 11.9 22 <0.0001 
HNE, ng/mL 13.0 5.0 – 15.4 17 0.4 0.2 – 0.8 14 <0.0001 
Pleiotropic cytokines  
IL-12, pg/mL 20.9  11.0 – 52.9 21 3.8 0.9 – 13.9 17 0.0007 
IFN-gamma, pg/mL 143 10 - 1271 21 14 5 – 52 17 0.0146 
GM-CSF, pg/mL 1.6 0.9 – 2.5 12 0.8  0.6 – 1.0 7 0.0378 
Anti-inflammatory cytokines        
IL-10, pg/mL 10.1 5.2 – 103.9 20 2.6 0.6 – 14.2 16 0.0056 
Page 36 of 70
For Review Only
  
 
 
Figure 1 - ICU subglottic aspirates are characterized by reduced microbiological diversity and the presence 
of more species recognized as potential respiratory pathogens than control secretions. (A) Semi-quantitative 
bacterial and fungal culture of subglottic aspirates. (B) 16S rRNA bacterial profiling of subglottic aspirates. 
Observed operational taxonomic units (OTUs) and Shannon alpha diversity are demonstrated. The boxplots 
show the upper and lower quartiles and median, whiskers represent the range. (C) Hierarchical clustering of 
subglottic aspirate samples by bacterial relative abundance at OTU level. The row above the heat map shows 
ICU samples (orange) and control samples (blue) where each column represents a patient’s sample. The 30 
most abundant bacterial OTUs are displayed on the heat map. A; Mann–Whitney U test, B; Kruskal-Wallis 
test, **p<0.01, ***p<0.001 (A; ICU n = 23, control n = 25. B/C; ICU n = 24, control n = 20).  
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Figure 2 - ICU aspirates are more dehydrated and viscous, and contained a greater concentration of dsDNA 
and MUC5B, but not MUC5AC, than control mucus. (A) Mucus shear viscosity was analyzed at 37°C. Values 
are expressed as pascal-seconds (Pa·s) at a shear rate of 1 s-1. (B) Aspirates were weighed before and after 
dehydration overnight at 80°C. The percentage solid was then calculated. (C) dsDNA concentration was 
quantified by Quant-iT assay kit. (D) Mucin MUC5B and MUC5AC concentrations were quantified by ELISA. 
Each dot represents a sample from an individual patient. Long horizontal bars indicate medians, shorter 
horizontal bars indicate interquartile range. Statistical analysis was by Mann–Whitney U test, *p < 0.05, 
**p<0.01, ****p<0.0001.  
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Figure 3 - ICU subglottic aspirates are dominated by high numbers of viable neutrophils, capable of 
phagocytosis. (A) Cells were extracted from subglottic aspirates by treatment with 0.08% DTT. Differential 
cell count was then performed using a hemacytometer and cytospin preparations. (B) Extracted cells were 
incubated with Annexin V and propidium iodide. Viable, early apoptotic and late apoptotic/necrotic cells were 
determined by flow cytometric gating of neutrophils. No significant difference between the two cohorts was 
demonstrated. (C) Cells were extracted from the whole blood of ICU patients or healthy volunteers (HV) 
using dextran sedimentation, or the mucus of ICU patients/control patients after treatment with 0.08% DTT. 
Extracted cells were incubated at 37°C for 1 hour with serum-opsonized pHrodo® green S. aureus 
Bioparticles. Phagocytosis was determined by flow cytometry. A negative control sample on ice was used in 
all experiments. Data in A and B are presented as box and whisker plots where the horizontal line depicts 
the median, boxes the interquartile range and whiskers the range. In C, each dot represents a sample from 
an individual. Long horizontal bars indicate medians, shorter horizontal bars indicate interquartile range. 
Statistical analysis was by Kruskal-Wallis test and Dunn’s post hoc test, *p<0.05, ****p<0.0001 (A; ICU n 
= 18, control n = 7. B; ICU n = 18, control n = 8).  
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Figure 4 - Purified ICU-derived mucin inhibits neutrophil function and this effect is reversible with mucolytic 
treatment. (A) Neutrophil chemotaxis was measured using carboxyfluorescein succinimidyl ester (CFSE)-
labeled neutrophils incubated within a transwell insert (3.0 µm pore size). The number of neutrophils that 
migrated from the apical compartment to the lower compartment (containing IL-8 at 10 ng/mL) at 3 hours 
was established. (B) Bacterial killing was determined using P. aeruginosa PA01 (opsonized using serum from 
the same donor who provided neutrophils) incubated with neutrophils for 30 minutes. Serial dilution on agar 
plates was performed, and colonies counted at 24 hours to derive a percentage reduction in colony forming 
units (CFU), measured against a sample without neutrophils. (C) Neutrophil phagocytosis pre- and post-
mucolytic treatment was measured. Cells were incubated in mucin for 30 minutes prior to treatment with 
0.08% dithiothreitol (DTT) for 5 minutes, centrifuged and re-suspended in a solution without mucin. 
Untreated cells and DTT-treated cells were then incubated at 37°C for 1 hour with pHrodo® green S. aureus 
Bioparticles® (opsonized using serum from the same donor who provided neutrophils). Phagocytosis was 
determined by flow cytometric gating of viable neutrophils with ingested particles versus a control sample on 
ice. Data are expressed as median and 95% confidence interval. Kruskal-Wallis test and Dunn’s post hoc 
test were used to compare the differences against the control without mucin. *p<0.05. (A; n = 6, B; n = 5; 
C n = 6).  
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Figure 5 - Purified subglottic mucin from ICU patients increases bacterial growth and invasion in bacterial-
epithelial co-culture experiments. The mucus layer of PSECs cultured at ALI was removed and replaced with 
50 µL of purified ICU-derived mucin (0, 5, 10 and 20 mg/mL), and incubated for 1 hour (37°C 5% CO2). P. 
aeruginosa [5µl (2x107 CFU/mL), strain PA01] was then applied apically and incubated for 7 hours. Bacterial 
growth in the mucin layer (A) and epithelial homogenate (B) was determined by serial dilution on agar 
plates, counting colony-forming units (CFU) at 24 hours. Data are expressed as median and 95% CI. 
Kruskal-Wallis test and Dunn’s post hoc test were used to compare samples and the control without mucin, 
*p<0.05, n = 4.  
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SUPPLEMENTARY METHODS 
 
Patients and volunteers 
ICU patients fulfilled the criteria described in the main paper. Exclusion criteria comprised 
age<18 years, known current or previous malignancy or radiotherapy to the upper 
aerodigestive tract, PaO2<8kPa on FiO2>0.7, positive end-expiratory pressure >15cmH2O, 
peak airway pressure >30cmH2O, heart rate >140 beats per minute, mean arterial pressure 
<60mmHg, bleeding diathesis (including platelet count <20x10
9 
per liter of blood or 
prothrombin time or activated partial thromboplastin time greater than 1.5 times the reference 
range) and poorly controlled intracranial pressure (>20mmHg if measured). 
 
Controls were recruited from elective theater lists of patients undergoing laryngeal 
examination under general anesthesia. Exclusion criteria comprised age<18 years, known 
current or previous malignancy or radiotherapy to the upper aerodigestive tract, abnormal 
subglottic/laryngeal mucosal appearances at clinic appointment or theater examination. 
 
Healthy volunteers (HV) were recruited from university staff, students and the general 
population as a control group allowing comparison with ICU blood-derived neutrophil 
phagocytosis levels. We recruited 16 HV, median age 67 (range 23 – 89) years, 50% were 
male. There was no significant difference in the age or sex distribution between these 
volunteers and the ICU cohort, p = 0.54
*
 and p = 0.43
†
 respectively. 
*
Mann–Whitney U test, 
† 
by Chi Squared test. 
 
A separate group of HV was recruited from university staff, students and the general 
population to provide blood to generate healthy neutrophils for in vitro experiments.  
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Collection of subglottic secretions, subglottic brushings and blood 
Eligible patients had subglottic secretions and brushings performed by a single experienced 
operator. Briefly, secretions were suctioned under direct vision from the subglottic region via 
a bronchoscope or laryngoscope. If subglottic secretion drainage (SSD) was being used (in 
the ICU patients), additional secretions were taken via this route. In control patients 
subglottic mucosal brushing was performed via the laryngoscope or bronchoscope. Whole 
blood was collected into 0.38% sodium citrate (final concentration). 
 
Processing of subglottic aspirates and whole blood 
If sufficient aspirate volumes were recovered a proportion was immediately frozen at -80°C 
until further analysis. The remainder was used fresh for leukocyte extraction and 
quantification. Aspirates were treated with 0.08% dithiothreitol (DTT) for 5 minutes to 
extract cells. Aspirates were then washed and passed through a 30-micron filter. Differential 
cell counts were performed using a hemocytometer. An experienced pathology technician 
analyzed and interpreted fixed, Giemsa-stained cytospin preparations. 
 
Citrated whole blood was separated into purified leukocytes, plasma and serum. Briefly, 
serum was prepared by adding 1M calcium chloride to plasma. Leukocytes were isolated by 
dextran sedimentation and discontinuous Percoll gradient separation.  
 
Bacterial identification in subglottic aspirates  
Semi-quantitative microbiology culture was performed by standardized microbiology culture 
techniques. In brief, samples were mixed with 0.5 mL 0.1% DTT solution and incubated for 
30 minutes followed by serial dilutions in 0.85% saline. Samples were then cultured at 37°C 
for 48 hours on: 1) chocolate agar incubated in air plus 5% CO2; 2) fastidious anaerobe agar 
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incubated anaerobically; 3) Sabouraud agar incubated in air. Colony types were then 
quantified and identified using matrix-assisted laser desorption/ionization time-of-flight mass 
spectrometry (MALDI-TOF MS). 
 
Nucleic acid extraction from subglottic aspirates was carried out using PowerLyzer 
PowerSoil® DNA Isolation Kit (MoBio, CA, USA) in accordance with the manufacturer’s 
instructions. Bacterial profiling utilized the 16S rRNA gene targeting variable region four 
based on the Schloss wet-lab MiSeq standard operating procedure (SOP) and resulting raw 
fastq data were processed using Mothur (version 1.31.2). Paired reads were merged and 
processed to remove sequences containing ambiguous bases, homopolymers >8bp and 
sequences with a length >275bp. Sequences were aligned to the SILVA database and 
chimeras were removed. The remaining sequences were classified using the RDP database 
and sequences not identified as bacteria were removed from the downstream analysis. 
Operational taxonomic units (OTUs) present in polymerase chain reaction (PCR) negative 
controls were removed and the positive control was removed. Reads were normalized by 
subsampling to 1270 reads per sample. Analysis and visualization of microbiome 
communities was conducted in R utilizing the phyloseq package. 
 
Quantification of inflammatory cytokines, complement factors, mucins, DNA, 
neutrophil proteases and the physical properties of subglottic aspirates 
Quantification of cytokines was performed by Meso Scale Discovery (MSD) technology 
using the V-PLEX Proinflammatory Panel 1 (human) kit. Quantification of IL-8 and GM-
CSF was performed separately using a U-PLEX kit (Meso Scale Diagnostics, MD, USA). 
Human neutrophil elastase was measured using Human PMN Elastase ELISA (Abcam, MA, 
USA). Double-stranded DNA was measured using a Quant-iT dsDNA fluorometric assay kit 
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(Thermofisher, MA, USA). The Cytometric Bead Array (CBA) Human Anaphylatoxin Kit 
(BD, NJ, USA) was utilized to quantify C5a, and its des-Arg derivative. Analysis was 
performed on a calibrated FACSCanto II flow cytometer (BD Biosciences, NJ, USA). All 
assays were performed according to the manufacturer’s instructions.  
 
Neutrophil viability  
Neutrophils were re-suspended in Annexin V buffer for 15 minutes on ice with 
allophycocyanin (APC)-conjugated Annexin V and propidium iodide (Thermofisher, MA, 
USA). A control tube contained unstained cells. Data were acquired immediately on a 
calibrated FACSCanto II flow cytometer (BD Biosciences, NJ, USA). 
 
Phagocytosis of pHrodo® Green Staphylococcus aureus Bioparticles® by neutrophils 
pHrodo® Green S. aureus Bioparticles® (Thermofisher, MA, USA) were opsonized by 
incubation at a 1:10 dilution in 50% Iscove's Modified Dulbecco's Medium (IMDM, 
Thermofisher, MA, USA) / 50% serum (from the same donor providing the neutrophils for 
any given experiment), for 30 minutes at 37°C. Bioparticles were then incubated with 
neutrophils for 90 minutes (end particle concentration 1 µg/mL). A sample was kept on ice 
acting as a “no phagocytosis” control. Cells were washed and data were acquired 
immediately on a calibrated FACSCanto II flow cytometer (Becton Dickinson Biosciences, 
NJ, USA), gating for viable neutrophils with ingested particles, against the no phagocytosis 
control. 
 
Killing of Pseudomonas by neutrophils 
Pseudomonas aeruginosa (strain PA01) was cultured overnight in Roswell Park Memorial 
Institute-1640 (RPMI) medium at 37°C. Optical density measurements were used to yield a 
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concentration of approximately 2x10
7 
colony forming units (CFU)/mL (confirmed by serial 
dilutions and incubation on LB agar plates). Bacteria were opsonized with 10% serum (from 
the same donor who provided neutrophils for any given experiment) for 30 minutes prior to 
co-culture with whole blood-derived neutrophils (1x10
7
 cells per mL) in ICU-derived mucin 
(in Hanks' Balanced Salt solution with Ca
2+ 
and Mg
2+
 (HBSS)) for 30 minutes (37°C 5% 
CO2). Subsequently the samples were incubated in 0.08% DTT/0.01% Triton X-100 for 30 
minutes. Bacterial viability was determined by serial dilution and incubation on LB agar 
plates. Plates were incubated for 24 hours at 37°C and CFU counted. A control sample 
without neutrophils was used to determine neutrophil-specific bacterial killing.  
 
Neutrophil chemotaxis 
Carboxyfluorescein succinimidyl ester (CFSE)-stained whole blood-derived healthy 
volunteer neutrophils (1x10
7
 cells per mL) were incubated (37°C 5% CO2) in the upper 
chamber of a transwell permeability support (3.0 µm pore size, Corning, NY, USA). Cells 
that had migrated into the lower chamber, containing reconstituted IL-8 solution (10 ng/mL, 
Sigma-Aldrich, Dorset, UK), were quantified at 3 hours, using a confocal fluorescent camera 
(Axio Imager II, Zeiss, Oberkochen, Germany) and automated software utilizing the JOBS 
module of NIS Elements (Nikon, Tokyo, Japan). A control sample comprised a well without 
IL-8-containing solution.  
 
Mucus analysis and mucin purification 
Shear viscosity of mucus was analyzed at 37°C using a Kinexus Pro (Malvern Instruments, 
Worcester, UK) with 60 mm parallel plates, according to the manufacturer’s instructions. A 
table of shear rates was produced over the range of 0 – 100 s
-1
. Analysis was performed on 
rSpace software (version 1.6, Malvern Instruments, Worcester, UK). 
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The percentage dry weight of mucus was calculated by using a microbalance to compare 
weight before and after drying the sample at 80°C overnight.  
 
MUC5AC and MUC5B protein expression was measured using ELISA. A volume of 100 µL 
of each sample was incubated in a 96-well plate at room temperature overnight. Plates were 
washed three times with PBS containing 0.05% Tween 20 and blocked with 1% casein for 2 
hours at room temperature. Plates were again washed three times with PBS and then 
incubated with 100 µL of primary monoclonal antibody for MUC5AC (45M1 mouse anti-
human MUC5AC (Abcam, MA, USA)), diluted 1/100 in antibody diluent (0.1% 
casein/0.05% Tween 20 in PBS)) or 100 µL of primary monoclonal antibody for MUC5B 
(EPR6920, rabbit anti-human MUC5B (Abcam, MA, USA)), diluted 1/200 in antibody 
diluent (0.1% casein/0.05% Tween 20 in PBS)) and incubated for 2 hours. 100 µL of 
secondary antibody was added and incubated for 2 hours (horseradish peroxidase-conjugated 
goat anti-mouse/rabbit (Dako, CA, USA)), diluted 1/5000 with antibody diluent). Finally 100 
µL of peroxidase substrate ABTS (2,2’-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid)) 
was added and the plate allowed to develop. Absorbance at 405 nm was measured. 
 
Individual subglottic aspirates, derived from ICU patients, were pooled and mixed with an 
equal volume of an enzyme inhibitor buffer cocktail, homogenized and centrifuged at 
10,000g, for 1 hour at 4°C. Mucin fractions were purified by cesium chloride density-
gradient centrifugation (starting density 1.42 g/mL) in a T-1170 ultracentrifuge (Centricon, 
USA) at 100,000g, for 48 hours at 4°C. Mucin-containing fractions were then recovered and 
extensively dialyzed against distilled water for 72 hours. Fractions were lyophilized for 72 
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hours using a vacuum freeze dryer (Shanghai Bilon Instrument, Shanghai, China) and stored 
at -20°C for future use. 
 
Primary subglottic epithelial cell (PSEC) culture and characterization 
PSECs were obtained from subglottic brushing samples taken from newly intubated theater 
attender controls. In brief, brushings were plated in serum-free Bronchial Epithelial Basal 
Medium (Lonza, Basel, Switzerland) supplemented with SingleQuots™ (Lonza, Basel, 
Switzerland) and antibiotics. Once 70-90% confluent, cells were passaged onto transwell 
inserts (0.4 µm pore size, Corning, NY, USA) and grown at air-liquid interface (ALI). Cells 
were studied 3–4 weeks post-seeding. 
  
Epithelial characteristics were confirmed by (a) light microscopic assessment for the presence 
of apical cilia and (b) trans-epithelial electrical resistance, measured using an epithelial volt-
ohmmeter (World Precision Instruments, FL, USA), according to the manufacturer’s 
instructions. 
 
A subset of samples underwent further characterization, including scanning electron 
microscopy of glutaraldehyde-fixed ALI cultures embedded in resin, performed using a 
Cambridge Steroscan 240 electron microscope. Cytokeratin staining was performed on 
methanol-fixed and permeabilized ALI cultures, using monoclonal anti-cytokeratin (pan-
reactive) antibody (raised in mouse), conjugated with Alexa Fluor® 647 (Biolegend, CA, 
USA), counter-stained with DAPI (4′,6-diamidino-2-phenylindole dihydrochloride) nuclear 
stain. Imaging was performed with a confocal fluorescent camera (Axio Imager II, Zeiss, 
Oberkochen, Germany). 
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Paraffin-embedded blocks and sections were also prepared. Briefly, ALI cultures were 
washed and then fixed with 4% paraformaldehyde for 20 minutes at room temperature. 
Subsequently the membrane was dehydrated through graded alcohols, submerged in xylene 
(VWR, Lutterworth, UK) for 20 minutes, twice, and then embedded in paraffin for 1 hour at 
60°C. Sections of the paraffin blocks were then cut to 5 µm thickness using a microtome. 
Sections were later de-waxed and stained in freshly filtered Carrazzi’s Haematoxylin 
(Thermofisher, MA, USA) for 1 minute, then counterstained with Eosin Y (Fisher Scientific, 
UK) for 2 minutes and dehydrated back through graded alcohols and xylene. The sections 
were then mounted with DPX (VWR, Lutterworth, UK) and analyzed using light microscopy. 
 
Bacterial-epithelial co-culture experiments 
PSECs were cultured at ALI in antibiotic-free medium for at least 24 hours prior to 
experimentation. The mucus layer on the PSECs was removed (by aspiration and washing) 
and replaced with 50 µL of purified ICU-derived mucin in HBSS, and incubated for 1 hour 
(37°C 5% CO2). P. aeruginosa [5µl (2x10
7
 CFU/mL), PA01] was then applied to the apical 
surface of the cells and incubated for 7 hours (37°C 5% CO2). The mucin layer was then 
removed by repeated washing. The epithelial layer was removed from the transwell insert and 
homogenized by repeated agitation. The samples were incubated in 0.08% DTT/0.01% Triton 
X-100 for 30 minutes. Bacterial growth in the mucin layer and epithelial homogenate was 
determined by serial dilution and incubation on LB agar plates. Plates were incubated for 24 
hours at 37°C and CFU counted. 
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SUPPLEMENTARY RESULTS 
 
Clinical characteristics of the ICU patient population 
Table E1 provides details for the ICU patient population, including the mix of surgical and 
medical patients included in the study, details of the type of ETT used, duration of 
mechanical ventilation, APACHE II score on admission to the ICU, comorbidities, outcome, 
use of antimicrobials, and culture results obtained from routine clinical practice.  
 
To investigate potential correlates between mucin concentrations in the subglottic aspirates 
and clinical status, total mucin concentrations in ICU subglottic aspirates were compared 
with various parameters. Subglottic mucin concentrations showed a weak, positive 
correlation with duration of intubation/mechanical ventilation and increasing age (Figure E2). 
 
Bacterial and fungal identification in subglottic aspirates  
Figure E1 (A and B) shows the variability in bacterial and fungal species/families identified 
by semi-quantitative bacterial/fungal culture, between ICU and control aspirates, as well as 
the organisms with the highest CFU count on semi-quantitative culture in each group.  
 
Bacterial 16S rRNA gene profiling allowed construction of nonmetric multidimensional 
scaling (nMDS) plots, based on Bray-Curtis distances, which demonstrate the similarities 
between the microbial communities sampled in each aspirate. Greater similarity is seen in the 
bacterial communities of the control aspirates (ie the blue “control” dots are clustered more 
closely, Figure E1C) compared to those from the ICU. Taxonomic classification also visually 
represents the greater diversity and similarity of subglottic bacterial communities across the 
ICU and control groups (Figure 1D). The percentage abundance of communities in the 
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ecosystem is demonstrated in Table E2.  
 
Neutrophil viability in purified ICU-derived mucin 
Given the distinct differences in phagocytic function and chemotaxis of neutrophils in higher 
mucin concentrations, we investigated if there was any difference in the proportion of 
neutrophils that were viable, apoptotic or necrotic, after incubation in purified ICU-derived 
mucin. No significant differences were found when comparing proportions in different 
concentrations of mucin (Figure E3). As there was a slight trend towards reduced viability at 
higher concentrations we included a viability marker and gated out non-viable cells in all 
flow cytometry-based experiments. 
 
Neutrophil mobility in purified ICU-derived mucin 
The videos in Figure E4 demonstrate that healthy blood-derived neutrophils incubated in high 
mucin concentrations appear unable to move. 
 
Characterization of PSECs 
To investigate potential interactions between infected mucus and the subglottic epithelium we 
developed a novel in vitro ALI model of human PSEC and characterized the model to 
determine how closely it recapitulated the in vivo environment (Figure E5). PSECs formed a 
cobblestone mucosa typical of airway epithelial cells (Figure E5A). An epithelial phenotype 
was confirmed by expression of pan-cytokeratin (Figure E5B), apical cilia were demonstrated 
at scanning electron microscopy (Figure E5C), and appropriate levels of trans-epithelial 
electrical resistance were recorded (Figure E5D). At ALI the cells demonstrated a highly 
differentiated pseudostratified respiratory epithelium with apical cilia (Figure E5E).  
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Appropriate trans-epithelial electrical resistance is a crucial feature of a normal epithelial 
membrane in vivo. We therefore used Ussing chambers to confirm epithelial resistance and 
the presence of key respiratory epithelial channels in our in vitro PSEC cultures at ALI 
(Figure E6). Production of mucus is also a key respiratory epithelial function, so we obtained 
apical aspirates of in vitro PSEC secretions at ALI and performed ELISAs on these samples. 
This confirmed the presence of the two key airway mucin MUC5AC and MUC5B (Figure 
E7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 53 of 70
For Review Only
 
SUPPLEMENTARY TABLES 
Page 54 of 70
For Review Only
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AntimicrobialsParticipant ETT
ETT cuff 
pressure 
(cmH2O)
29ICU_1
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Table E1. Clinical details of ICU patients.  
APACHE II score was calculated at the time of admission to ICU. The 3 right hand columns 
refer to samples obtained as part of routine clinical care (ie separate to this study); a blank 
cell indicates no sample was sent. VAP diagnosis was made by the clinical team. In the ETT 
column, - indicates information unavailable. Antimicrobials listed include agents used at the 
time of subglottic aspiration or during the ICU admission prior to sampling. 
APACHE, Acute Physiology and Chronic Health Evaluation; BAL, bronchoalveolar lavage; 
CAP, community-acquired pneumonia; COPD, chronic obstructive pulmonary disease; DM2, 
type 2 diabetes mellitus; ETT, endotracheal tube; HAP, hospital-acquired pneumonia; HTN, 
hypertension; ICU, intensive care unit; IHD, ischemic heart disease; SSD, subglottic 
secretion drainage; VAP, ventilator-associated pneumonia.  
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Relative abundance (%) 
Taxa FDR-Adj. P Mean of Control Mean of ICU 
Actinomyces 0.000007471 1.29 0.07 
Veillonellaceae_unclassified 0.000084855 2.69 0.03 
Veillonella 0.000126457 18.01 1.21 
Streptococcus 0.000126457 1.68 0.23 
Streptococcus 0.000126457 1.01 0.17 
Campylobacter 0.000126457 0.68 0.04 
Rothia 0.000126457 0.43 0.12 
TM7_genus_incertae_sedis 0.000126457 0.49 0.01 
Selenomonas 0.000317446 0.82 0.05 
Megasphaera 0.000451107 3.20 0.64 
Leptotrichia 0.001830059 0.79 0.01 
Prevotella 0.002455293 4.80 1.36 
Veillonellaceae_unclassified 0.002455293 1.41 0 
Veillonella 0.002455293 0.96 0 
Oribacterium 0.002455293 0.19 0.05 
Prevotella 0.002679397 3.79 0.21 
Lachnospiraceae_unclassified 0.002679397 0.23 0.01 
Granulicatella 0.003104225 0.34 0.08 
Gemella 0.003116766 0.39 0.20 
Streptococcus 0.005361409 4.03 1.37 
Prevotella 0.007894449 23.39 11.93 
Leptotrichia 0.012684256 1.14 0.07 
Lachnospiraceae_unclassified 0.017543293 0.32 0.07 
Fusobacterium 0.022312655 2.10 0.89 
Selenomonas 0.022312655 0.53 0.21 
Anaeroglobus 0.025712556 0.28 0.22 
Prevotella 0.029567233 0.40 0.09 
Lactobacillus 0.031428462 0.02 2.12 
Paraprevotella 0.031428462 0.99 0.54 
Mycoplasma 0.031428462 0.02 0.52 
Enterococcus 0.031946906 0 7.37 
Oribacterium 0.039017981 0.22 0.03 
Pasteurellaceae_unclassified 0.040297793 1.83 0.87 
Veillonella 0.040982332 4.55 1.28 
Staphylococcus 0.044489587 0.08 3.12 
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Table E2. Subglottic aspirates were processed using 16S rRNA bacterial profiling. 
Significantly distinct operational taxonomic units (OTUs) with percentage abundance per 
group. Statistical analysis by Mann-Whitney U test adjusted for false discovery rate 
(FDR). ICU n = 24, control n = 20. 
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SUPPLEMENTARY FIGURE LEGENDS 
 
Figure E1 
(A) Subglottic aspirates underwent semi-quantitative bacterial/fungal culture. The number of 
samples containing each genus/family was recorded. Significant results are demonstrated for 
each genus (Streptococcus, Rothia, Actinomyces, Candida, Enterococcus). The family 
Enterobacteriaceae was also included due to the number of different individual species 
recovered. (B) The organism with the highest CFU count was recorded. Significant results are 
demonstrated for the genus (Streptococcus) and family (Enterobacteriaceae). (C) Subglottic 
aspirates were processed using 16S rRNA bacterial profiling. Nonmetric multidimensional 
scaling (nMDS) plots based on Bray-Curtis distances were generated. The two most distinct 
taxonomic variables are plotted as correlations with control and ICU samples. (D) Taxonomic 
classification of bacterial reads demonstrating the 20 most common operational taxonomic 
units (OTUs). A/B; Fisher’s exact test, D; Mann-Whitney U test, *p<0.05, **p<0.01, 
***p<0.001 ****p<0.0001 (A/B; ICU n = 23, control n = 25, C/D; ICU n = 24, control n = 
20).  
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Figure E2  
Increased total mucin concentration in subglottic aspirates is associated with length of 
intubation and mechanical ventilation, and age. Total mucin concentrations (MUC5B and 
MUC5AC) in ICU aspirates were correlated with clinical parameters of length of continuous 
intubation and mechanical ventilation at the time of sampling (A) and the patient’s age (B). 
Data were analyzed by linear regression. 
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Figure E3 
Whole blood-derived neutrophils from healthy volunteers were incubated at 37°C in purified 
mucin (from ICU patients) for 1 hour prior to flow cytometric analysis of viability using 
Annexin V (Ann V) and propidium iodide (PI). (A) Data are expressed as median and 95% 
CI. Kruskal-Wallis test and Dunn’s post hoc test were used to compare the differences 
against the control without mucin. No significant differences were observed. (B) 
Representative flow cytometry plot showing viable cells (Ann V negative, PI negative [Q3]), 
early apoptotic cells (Ann V positive, PI negative [Q1]), and the mixed population of late 
apoptotic and necrotic cells (PI positive [Q2 and Q4]). (C) Representative flow cytometry 
plot showing neutrophil phagocytosis as determined by pHrodo® Green S. aureus 
Bioparticles®. A sample was kept on ice acting as a “no phagocytosis” control. Gating was 
performed to determine the percentage of neutrophils with ingested particles, against the no 
phagocytosis control. SSC, Side Scatter. 
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Figure E4 
CFSE-stained whole blood-derived neutrophils from healthy volunteers were incubated in a 
96-well plate at 37°C containing purified ICU-derived mucin. Video (A) contained no mucin 
and video (B) contained mucin 20 mg/mL. 
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Figure E5 
(A) Submerged culture of human PSECs, with a typical cobblestone appearance on light 
microscopy. (B) Same sample after passage and air-liquid interface (ALI) culture. Epithelial 
phenotype was confirmed by expression of pan-cytokeratin (red fluorescence) and nuclei 
counterstained with DAPI (blue). (C) Trans-epithelial electrical resistance measurements 
across epithelial cells at ALI. Horizontal line represents median value. Images are 
representative of 9 separate experiments. (D) Scanning electron micrograph of epithelial cells 
at ALI demonstrating apical cilia. (E) Brightfield micrograph image of a cross-section of 
cells at ALI culture (paraffin-embedded), demonstrating highly differentiated pseudostratified 
respiratory epithelium (including basal, ciliated, and goblet cells) supported on a transwell 
membrane. 
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Figure E6 
Ussing chamber studies demonstrate the electrophysiological properties of PSECs at ALI 
over time. Human PSECs grown on Snapwells (37°C 5% CO2) were assessed in an Ussing 
chamber. Short-circuit current (Isc) values reflect anion (Cl
-
) secretion and/or cation 
absorption (Na
+
). Exposure of the epithelium to 10µM amiloride (AMIL) blocked the apical 
epithelial sodium channels (ENaC) in the polarized epithelial cells. 10µM forskolin (FSK) 
was then added to activate cAMP cascades and caused a significant elevation in whole 
epithelial current. 20µM inh172, a specific cystic fibrosis transmembrane conductance 
regulator (CFTR) inhibitor, reversed this elevated Isc current, which demonstrated that the 
majority of the forskolin response was attributable to CFTR. Resistance was monitored by 
applying 5mV voltage pulses at 30 second intervals and monitoring the change in Isc (not 
shown). The resistance was multiplied by the surface area of the transwell, to give an 
electrical resistance value in Ω.cm
2
. Resistance values shown are initial measurements. Data 
from one representative experiment.  
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Figure E7 
Apical secretions collected from PSECs at ALI, demonstrating airway mucins MUC5B and 
MUC5AC. Mucin concentrations were quantified from apical aspirates and measured by 
ELISA. Horizontal bars depict median values, n = 11 MUC5B, n = 9 MUC5AC. 
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Figure E1 - (A) Subglottic aspirates underwent semi-quantitative bacterial/fungal culture. The number of 
samples containing each genus/family was recorded. Significant results are demonstrated for each genus 
(Streptococcus, Rothia, Actinomyces, Candida, Enterococcus). The family Enterobacteriaceae was also 
included due to the number of different individual species recovered. (B) The organism with the highest CFU 
count was recorded. Significant results are demonstrated for the genus (Streptococcus) and family 
(Enterobacteriaceae). (C) Subglottic aspirates were processed using 16S rRNA bacterial profiling. Nonmetric 
multidimensional scaling (nMDS) plots based on Bray-Curtis distances were generated. The two most 
distinct taxonomic variables are plotted as correlations with control and ICU samples. (D) Taxonomic 
classification of bacterial reads demonstrating the 20 most common OTUs. A/B; Fisher’s exact test, D; 
Mann-Whitney U test, *p<0.05, **p<0.01, ***p<0.001 ****p<0.0001 (A; ICU n = 23, control n = 15, B; 
ICU n = 19, control n = 24, C/D; ICU n = 24, control n = 20).  
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Figure E2 - Increased total mucin concentration in subglottic aspirates is associated with length of intubation 
and mechanical ventilation, and age. Total mucin concentrations (MUC5B and MUC5AC) in ICU aspirates 
were correlated with clinical parameters of length of continuous intubation and mechanical ventilation at the 
time of sampling (A) and the patient’s age (B). Data were analyzed by linear regression and Spearman’s 
rank correlation test.  
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Figure E3 - Whole blood-derived neutrophils from healthy volunteers were incubated at 37°C in purified 
mucin (from ICU patients) for 1 hour prior to flow cytometric analysis of viability using Annexin V (Ann V) 
and propidium iodide (PI). (A) Data are expressed as median and 95% CI. Kruskal-Wallis test and Dunn’s 
post hoc test were used to compare the differences against the control without mucin. No significant 
differences were observed. (B) Representative flow cytometry plot showing viable cells (Ann V negative, PI 
negative), early apoptotic cells (Ann V positive, PI negative), and the mixed population of late apoptosis and 
necrotic cells (PI positive).  
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Figure E5 - (A) Submerged culture of human PSECs, with a typical cobblestone appearance on light 
microscopy. (B) Same sample after passage and air-liquid interface (ALI) culture. Epithelial phenotype was 
confirmed by expression of pan-cytokeratin (red fluorescence) and nuclei counterstained with DAPI (blue). 
(C) Trans-epithelial electrical resistance measurements across epithelial cells at ALI. Horizontal line 
represents median value. Images are representative of 9 separate experiments. (D) Scanning electron 
micrograph of epithelial cells at ALI demonstrating apical cilia. (E) Brightfield micrograph image of a cross-
section of cells at ALI culture (paraffin-embedded), demonstrating highly differentiated pseudostratified 
respiratory epithelium (including basal, ciliated, and goblet cells) supported on a transwell membrane.  
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Figure E6 - Ussing chamber studies demonstrate the electrophysiological properties of PSECs at ALI over 
time. Human PSECs grown on Snapwells (37°C 5% CO2) were assessed in an Ussing chamber. Short-circuit 
current (Isc) values reflect anion (Cl-) secretion and/or cation absorption (Na+). Exposure of the epithelium 
to 10µM amiloride (AMIL) blocked the apical epithelial sodium channels (ENaC) in the polarized epithelial 
cells. 10µM forskolin (FSK) was then added to activate cAMP cascades and caused a significant elevation in 
whole epithelial current. 20µM inh172, a specific cystic fibrosis transmembrane conductance regulator 
(CFTR) inhibitor, reversed this elevated Isc current, which demonstrated that the majority of the forskolin 
response was attributable to CFTR. Resistance was monitored by applying 5mV voltage pulses at 30 second 
intervals and monitoring the change in Isc (not shown). The resistance was multiplied by the surface area of 
the transwell, to give an electrical resistance value in Ω.cm2. Resistance values shown are initial 
measurements. Data from one representative experiment.  
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Figure E7 - Apical secretions collected from PSECs at ALI, demonstrating airway mucins MUC5B and 
MUC5AC. Mucin concentrations were quantified from apical aspirates and measured by ELISA. Horizontal 
bars depict median values, n = 11 MUC5B, n = 9 MUC5AC.  
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